It is not uncommon for those with smoking cessation iss […]
It is not uncommon for those with smoking cessation issues to be confused about the difference between a Nasal Sprayer and a Nicotine Nasal Spray. To better understand the difference between these two devices, it is important to understand the mechanics of how each works. The main differences between the two devices are found in how they are used, and also the ingredients that are contained in each product. These differences have created new options for people who are interested in quitting smoking, but are still unsure which treatment method is best for them.
First, let's look at how a Nasal Sprayer works. Unlike the Nicotine Patch or Nicotine Gum, the nasal sprayer does not go into the throat area, but instead reaches out into the nose and opens up the nostrils so that a stream of mist can be released into the nose. When this occurs, the person only has to spray the mist into their nose once to get the effects. Once this mist is sprayed, it is not hard to remove it from the body. There is no residue left in the system and the symptoms that come along with smoking are not experienced.
Another difference is found in how the two products work when it comes to the ingredients that are contained in both products. The main active ingredient in both the Nasal Sprayer and the Nicotine Nasal Spray is a substance called Narax. Narax is a clear, odorless drug that has been clinically proven to reduce the severity of many cold symptoms. It has also been shown to be effective at reducing the severity of certain allergies as well. A nasal spray intranasal midazolam, however, uses the same Narax substance but with a lower concentration to reduce the effectiveness of the medication.
With this information in mind, one could assume that the Nasal Sprayer is more effective for treating and preventing colds than the nicotine nasal sprayer. But this is not the case. In fact, there were two pilot studies that compared the efficacy of the Nasal Sprayer with the nicotine replacement therapy. Both therapies resulted in similar numbers of patients who quit smoking. The reason why fewer people quit using the Nasal Sprayer is because there is no nicotine involved.
The new drug however, works differently. Users of the new Nasal Sprayer must first drink a small amount of the drug (two milliliters) under their tongue prior to inhaling it through the Nasal Sprayer tube. This allows for maximum absorption through the mucous membranes. The second step is then to take a small dose of the drug, inhale it through the tube, and repeat the procedure several times a day. After four to six weeks of this repeat strategy, most patients have no longer any coughs or other symptoms associated with smoking.
The study concluded that there were no significant side effects associated with Nasal Sprayer use. One small headache was reported in one patient, and this problem usually went away in about a week with the discontinuation of Nasal Sprays. The study was a double blind trial, meaning that there was no direct treatment provided by the researchers; instead, they randomly chose participants to receive either a placebo or a real, working anti-smoking drug.